Cargando…
ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells
ERBB3 is an emerging target for cancer therapy among the EGFR family. Contrary to resistance against EGFR and ERBB2 targeting, the genetic inhibition of ERBB3 results in anti-tumorigenic in HCT116 colon cancer cells harboring constitutively active KRAS and PIK3CA mutations. Still, the anti-tumorigen...
Autores principales: | Lee, Hyunji, Lee, Hyunjung, Chin, Hyunjung, Kim, Kyoungmi, Lee, Daekee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148128/ https://www.ncbi.nlm.nih.gov/pubmed/24970817 |
Ejemplares similares
-
STAT3‐mediated MLST8 gene expression regulates cap‐dependent translation in cancer cells
por: Lee, Hyunji, et al.
Publicado: (2020) -
ERBB3-dependent AKT and ERK pathways are essential for atrioventricular cushion development in mouse embryos
por: Kim, Kyoungmi, et al.
Publicado: (2021) -
Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target
por: Iyer, Sweta, et al.
Publicado: (2020) -
The great migration of Bax and Bak
por: Edlich, Frank
Publicado: (2015) -
Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
por: Zong, Wei-Xing, et al.
Publicado: (2003)